RNU6-445P

Across TCGA pan-cancer cohorts, RNU6-445P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-445P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-445P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-445P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

LUAD, LGG, and CESC are the cancer types where RNU6-445P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.206	0.767	.006	63	view →
LGG	OS	Tertile	All	0.021	0.896	<.001	36	view →
CESC	DFS	Tertile	II,III,IV	0.193	0.705	.045	18	view →
STAD	OS	Tertile	IV	0.805	0.283	.031	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-445P–LUAD (DFS)

Open the LUAD breakdown →